gastro-2017-scientifictracks-abstracts

5 / 42

Page 31
Notes:
conferenceseries.com
Volume 7, Issue 3 (Suppl) J Gastrointest Dig Syst, an open access journal
ISSN: 2161-069X Gastro 2017
June 12-13, 2017
June 12-13, 2017 Rome, Italy
11th Global
GastroenterologistsMeeting
Surgical therapy: A review and technological innovations
Paolo Urciuoli, Francesco Falb and Andrea Biancucci
Sapienza University of Rome, Italy
American Gastroenterologists Association 2008 Guidelines suggests anti-reflux surgery to be reserved for patients with esophagitis
and intolerance to PPI and patients with poor control of the gastro-esophageal reflux symptoms, especially regurgitation.
Laparoscopic Nissen-Rossetti fundoplication has become the gold standard, being a well-tolerated operation and considering its good
outcome in terms of symptoms relief. In 1939, RudolphNissen improvised a fundoplication to protect an esophagogastric anastomosis.
Some years later, he performed this procedure to treat gastro-esophageal reflux disease and published the first description of the
procedure in 1956. What we now call Nissen-Rossetti fundoplication is the result of the contribution by Nissen’s favorite pupil, Marco
Rossetti. Nissen-Rossetti fundoplication consists in an extensive mobilization of the posterior wall of the stomach, which enables a
loose wrap of the anterior wall to be used for the total wrap, without the division of the short gastric vessels. This procedure showed
good results in term of post-operative dysphagia. With the extensive application of laparoscopic surgery during the 1990s, the volume
of anti-reflux surgery increased. At the present time, Nissen-Rossetti compare favorably in terms of mortality and morbidity with
appendectomy and cholecystectomy. Where is anti-reflux surgery going from now on? Although as of now robot-assisted surgery still
has an unacceptable high cost for benign pathology, numerous studies are reporting comparable results in terms of outcomes versus
laparoscopic surgery. An interesting new device is LINX©, or Magnetic Sphincter Augmentation (MSA), a small flexible band of
interlinked titanium beads with magnetic cores that works by restoring the continence of the lower esophageal sphincter. This device
can be easily placed around the gastro-oesophageal junction in about 30 minutes. However, it needs longer follow-up and has some
limitation: it can’t be used in hiatal hernias larger than 3 cm, the safety and effectiveness of the LINX device has not been evaluated
in patients with Barrett's esophagus or grade C or D (LA classification) esophagitis and in patients with electrical implants such as
pacemakers and defibrillators, or other metallic, abdominal implants. LNR procedure should be considered the gold standard to treat
patient with refractory GERD. REFLUX trial concluded that a surgical policy is probably cost-effective, considering LNR in 5 years
follow-up provided a better health-related quality of life compared with medical management. Waiting for a mini-invasive techniques
standardization and long term follow up, patients should be aware of the safeness and feasibility of laparoscopic Nissen-Rossetti
fundoplication.
Biography
Paolo Urciuoli completed his Graduation at University of Rome "La Sapienza" in 1984. In November 1984, he passed the state examination for the qualification to
the profession of Surgeon Doctor at University of Rome "La Sapienza". In 1989, he specialized in General Surgery. In 2000, he specialized in Vascular Surgery. He
completed his internship in Surgery General and Colo-proctology at Thomas Jefferson University in Philadelphia, USA. Since 1990, he is a Researcher at Institute
of Surgical Clinic III (currently Department of Surgical Sciences).
Paolo Urciuoli et al., J Gastrointest Dig Syst 2017, 7:3(Suppl)
DOI: 10.4172/2161-069X-C1-049